BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21649637)

  • 1. Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro.
    Whyte LS; Ford L; Ridge SA; Cameron GA; Rogers MJ; Ross RA
    Br J Pharmacol; 2012 Apr; 165(8):2584-97. PubMed ID: 21649637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors.
    Chicca A; Marazzi J; Gertsch J
    Br J Pharmacol; 2012 Dec; 167(8):1596-608. PubMed ID: 22646533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
    Booker L; Kinsey SG; Abdullah RA; Blankman JL; Long JZ; Ezzili C; Boger DL; Cravatt BF; Lichtman AH
    Br J Pharmacol; 2012 Apr; 165(8):2485-96. PubMed ID: 21506952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
    Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
    Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoids are expressed in bone marrow stromal niches and play a role in interactions of hematopoietic stem and progenitor cells with the bone marrow microenvironment.
    Jiang S; Zagozdzon R; Jorda MA; Parmar K; Fu Y; Williams JS; Wood JA; Makriyannis A; Banu N; Avraham S; Groopman JE; Avraham HK
    J Biol Chem; 2010 Nov; 285(46):35471-8. PubMed ID: 20826813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing roles of CB
    Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
    Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55.
    Sharir H; Console-Bram L; Mundy C; Popoff SN; Kapur A; Abood ME
    J Neuroimmune Pharmacol; 2012 Dec; 7(4):856-65. PubMed ID: 22454039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice.
    Izzo AA; Capasso R; Aviello G; Borrelli F; Romano B; Piscitelli F; Gallo L; Capasso F; Orlando P; Di Marzo V
    Br J Pharmacol; 2012 Jun; 166(4):1444-60. PubMed ID: 22300105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
    Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
    Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.
    Bátkai S; Mukhopadhyay P; Horváth B; Rajesh M; Gao RY; Mahadevan A; Amere M; Battista N; Lichtman AH; Gauson LA; Maccarrone M; Pertwee RG; Pacher P
    Br J Pharmacol; 2012 Apr; 165(8):2450-61. PubMed ID: 21470208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T; Ueno S; Obara Y; Nakahata N
    J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A putative 'pre-nervous' endocannabinoid system in early echinoderm development.
    Buznikov GA; Nikitina LA; Bezuglov VV; Francisco ME; Boysen G; Obispo-Peak IN; Peterson RE; Weiss ER; Schuel H; Temple BR; Morrow AL; Lauder JM
    Dev Neurosci; 2010 Mar; 32(1):1-18. PubMed ID: 19907129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte Colony-Stimulating Factor Enhances Brain Repair Following Traumatic Brain Injury Without Requiring Activation of Cannabinoid Receptors.
    Song S; Kong X; Borlongan C; Sava V; Sanchez-Ramos J
    Cannabis Cannabinoid Res; 2021; 6(1):48-57. PubMed ID: 33614952
    [No Abstract]   [Full Text] [Related]  

  • 15. Endocannabinoids drive the acquisition of an alternative phenotype in microglia.
    Mecha M; Feliú A; Carrillo-Salinas FJ; Rueda-Zubiaurre A; Ortega-Gutiérrez S; de Sola RG; Guaza C
    Brain Behav Immun; 2015 Oct; 49():233-45. PubMed ID: 26086345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction.
    Hutch CR; Hillard CJ; Jia C; Hegg CC
    Neuroscience; 2015 Aug; 300():539-53. PubMed ID: 26037800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis.
    Richardson D; Pearson RG; Kurian N; Latif ML; Garle MJ; Barrett DA; Kendall DA; Scammell BE; Reeve AJ; Chapman V
    Arthritis Res Ther; 2008; 10(2):R43. PubMed ID: 18416822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones.
    Straiker A; Wager-Miller J; Hutchens J; Mackie K
    Br J Pharmacol; 2012 Apr; 165(8):2660-71. PubMed ID: 22014238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
    Desroches J; Charron S; Bouchard JF; Beaulieu P
    Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The endocannabinoid system and bone].
    Pura M; Vaňuga P
    Vnitr Lek; 2016; 62(9 Suppl 3):99-102. PubMed ID: 27734700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.